Link Cell Therapies is a biotechnology company that specializes in cancer cell therapy research and development services.
Link Cell Therapies has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Link Cell Therapies's investors include Wing Venture Capital, Samsara BioCapital, Bristol-Myers Squibb, Sherpa Healthcare Partners, Johnson & Johnson Innovation.
Link Cell Therapies is headquartered in San Francisco, United States.
Link Cell Therapies is a biotechnology company that specializes in cancer cell therapy research and development services.
Link Cell Therapies is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Link Cell Therapies — Funding & Investors." VCBacked, December 15, 2025, https://www.vcbacked.co/company/link-cell-therapies. Accessed August 1, 2026.
VCBacked. (2025). Link Cell Therapies — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/link-cell-therapies
{{cite web |title=Link Cell Therapies — Funding & Investors |url=https://www.vcbacked.co/company/link-cell-therapies |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated